SCHEMBL20127643

SCHEMBL20127643

c1ccc2c(c1)ccc1cccc(-c3c4ccccc4c(-c4c5oc6ccccc6c5cc5c4oc4ccccc45)c4ccccc34)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALOX5 P09917 2/20 0.40
AHR P35869 5/20 0.38
MAPT P10636 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
MEN1 O00255 1/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP1A2 P05177 3/20 0.34
ABCG2 Q9UNQ0 2/20 0.34
CYP1A1 P04798 1/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
PAX8 Q06710 1/20 0.34
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127437 0.92 SOS1 (0.39) TDP1L3MBTL1ALOX5AHRMAPT
SCHEMBL20127404 0.89 ALOX5 (0.43) TDP1L3MBTL1ALOX5AHRMAPT
SCHEMBL10122340 0.88 ALOX5 (0.43) ALOX5AHRMAPTMEN1KMT2A
SCHEMBL20127637 0.87 ALOX5 (0.40) TDP1L3MBTL1ALOX5AHRMAPT
SCHEMBL12768098 0.87 ALOX5 (0.46) TDP1L3MBTL1ALOX5AHRMAPT
SCHEMBL20127671 0.86 L3MBTL1 (0.41) TDP1L3MBTL1ALOX5AHRMAPT
SCHEMBL20127648 0.86 TDP1 (0.40) TDP1L3MBTL1ALOX5AHRMAPT
SCHEMBL19081653 0.84 ALOX5 (0.41) TDP1L3MBTL1ALOX5AHRMAPT
SCHEMBL19081453 0.84 ALOX5 (0.41) TDP1L3MBTL1ALOX5AHRMAPT
SCHEMBL12768058 0.83 ALOX5 (0.49) TDP1L3MBTL1ALOX5AHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 TDP1 3427/4885L3MBTL1 1670/4885ALOX5 4115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.